Desmin Antibody - DES Muscle Lineage Marker

Desmin (DES) Antibodies for Muscle Lineage Research

Desmin (DES) is a muscle-specific intermediate filament protein that plays a central role in maintaining the structural organization and mechanical integrity of muscle cells. It is expressed in skeletal, cardiac, and smooth muscle tissues, where it forms a cytoplasmic filament network linking contractile elements to cellular architecture. Desmin antibodies are widely used to detect DES expression in normal tissues and tumors, where expression patterns provide important insight into muscle differentiation and cellular lineage.

In normal tissues, Desmin is strongly expressed in muscle cells, while epithelial, lymphoid, and most non-muscle tissues show minimal to no expression. In cancer, Desmin expression is retained in tumors of muscle origin, making it a valuable marker for identifying myogenic differentiation and distinguishing muscle-derived tumors from non-myogenic malignancies.

Applications of Desmin Antibodies

Desmin antibodies are used across multiple research applications to evaluate muscle differentiation and protein expression. In immunohistochemistry, these antibodies enable visualization of cytoplasmic staining patterns in muscle cells within formalin-fixed, paraffin-embedded tissues, supporting identification of skeletal, cardiac, and smooth muscle components as well as tumors with myogenic differentiation.

In addition to tissue-based analysis, Desmin antibodies are used in immunodetection assays such as western blot and ELISA to assess protein expression in cell lysates and biological samples. These approaches support both qualitative and quantitative evaluation of DES expression across different experimental systems.

Desmin Expression in Normal and Cancer Tissues

Desmin expression is highly specific to muscle tissues, including skeletal muscle fibers, cardiac myocytes, and smooth muscle layers of organs such as the gastrointestinal tract and vasculature. This restricted expression pattern makes it a reliable marker for identifying muscle lineage in tissue-based studies.

In cancer, Desmin is commonly expressed in tumors of muscle origin, including leiomyomas, leiomyosarcomas, and rhabdomyosarcomas, where cytoplasmic staining reflects myogenic differentiation. In contrast, most carcinomas and non-myogenic tumors show little to no Desmin expression, supporting its use in distinguishing mesenchymal tumors from epithelial malignancies and aiding in tumor classification.

Tissue Microarray (TMA) Analysis of Desmin Antibodies

Tissue microarray (TMA) analysis enables large-scale evaluation of Desmin expression across diverse normal and cancer tissues under standardized experimental conditions. Desmin antibodies applied to TMA panels allow direct comparison of staining patterns across hundreds of tissue cores, providing a comprehensive view of DES distribution.

In TMA-based studies, strong staining is consistently observed in muscle tissues and tumors with myogenic differentiation, while non-muscle tissues remain largely negative. This contrast supports the specificity of Desmin as a muscle lineage marker and highlights its value in large-scale tissue profiling, biomarker validation, and comparative cancer research.

Explore Desmin Antibody Products

A range of Desmin antibody reagents are available to support different research applications, including immunohistochemistry and other immunodetection assays. These antibodies enable reliable detection of DES expression across a variety of sample types and experimental formats.

A selection of Desmin antibody products is shown below to support a range of research applications.